⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2779452 | 0.71 | — | — | |
| Hydrochloric Acid SCHEMBL29558253 | 0.69 | — | — | |
| Hydrochloric Acid SCHEMBL26625489 | 0.69 | — | — | |
| SCHEMBL28008807 | 0.69 | — | — | |
| SCHEMBL30068968 | 0.67 | — | — | |
| SCHEMBL31570731 | 0.67 | — | — | |
| SCHEMBL29935635 | 0.67 | — | — | |
| SCHEMBL29452685 | 0.65 | — | — | |
| Cyclooctane SCHEMBL27994201 | 0.65 | — | — | |
| Cycloheptane SCHEMBL28002455 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1916 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240217968-A1 | PHARMACEUTICAL COMPOUND | Duke Street Bio Limited (GB) | 2024-07-04 | — | — | US | claimed |
| CN-118203585-A | Pharmaceutical use of ENPP1 inhibitors | 上海翊石医药科技有限公司 | 2024-06-18 | — | — | CN | claimed |
| CN-118146236-A | Substituted dihydrothienoazaheteroaryl derivatives, methods of preparation and use of prodrugs thereof | 上海翊石医药科技有限公司 | 2024-06-07 | — | — | CN | claimed |
| WO-2024115465-A1 | PHARMACEUTICAL COMPOUNDS AS PARP7 AND/OR PARP1 INHIBITORS | Duke Street Bio Limited (GB) | 2024-06-06 | — | — | WO | claimed |
| US-20240115553-A1 | COMPOSITIONS AND METHODS FOR TREATING BRAIN INJURY | AZEVAN PHARMACEUTICALS, INC. (US) | 2024-04-11 | — | — | US | claimed |
| EP-4313300-A1 | PHARMACEUTICAL COMPOUND | Duke Street Bio Limited (GB) | 2024-02-07 | — | — | EP | claimed |
| CN-117460723-A | Pharmaceutical compounds | 杜克街生物有限公司 | 2024-01-26 | — | — | CN | claimed |
| CN-117417355-A | Fused heterocyclic compound, preparation method and application thereof | 上海翊石医药科技有限公司 | 2024-01-19 | — | — | CN | claimed |
| CN-117069720-A | 5-HT 2A Receptor agonist, preparation method and application thereof | 上海翊石医药科技有限公司 | 2023-11-17 | — | — | CN | claimed |
| CN-111943890-B | Pharmaceutical compounds | 艾欧米制药有限公司 | 2023-10-31 | — | — | CN | claimed |
| WO-2004050636-A2 | IMIDAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2004-06-17 | — | — | WO | claimed |
| US-20040038978-A1 | Chemical compounds | LILLY ICOS LLC, A DELAWARE CORPORATION | 2004-02-26 | — | — | US | claimed |
| EP-1390361-A2 | MELANOCORTIN RECEPTOR LIGANDS | THE PROCTER & GAMBLE COMPANY (US) | 2004-02-25 | — | — | EP | claimed |
| EP-1366050-A2 | CONDENSED PYRAZINDIONE DERIVATIVES AS PDE INHIBITORS | Lilly Icos LLC (US) | 2003-12-03 | — | — | EP | claimed |
| US-20030109556-A1 | Melanocortin receptor ligands | THE PROCTER & GAMBLE COMPANY | 2003-06-12 | — | — | US | claimed |
| WO-2003037895-A1 | 4-(6-MEMBERED)-HETEROARYL ACYL PYRROLIDINE DERIVATIVES AS HCV INHIBITORS | GLAXO GROUP LIMITED (GB) | 2003-05-08 | — | — | WO | claimed |
| US-6559100-B1 | Herbicidal activity of the substituted 2-benzoylcyclohexane-1,3-diones of the formula I was demonstrated by greenhouse experiments | BASF AKTIENGESELLSCHAFT (DE) | 2003-05-06 | — | — | US | claimed |
| WO-2002085925-A2 | MELANOCORTIN RECEPTOR LIGANDS | THE PROCTER & GAMBLE COMPANY (US) | 2002-10-31 | — | — | WO | claimed |
| WO-2002038563-A2 | CONDENSED PYRAZINDIONE DERIVATIVES AS PDE INHIBITORS | LILLY ICOS LLC (US) | 2002-05-16 | — | — | WO | claimed |
| US-5422349-A | Renin inhibitors | G. D. SEALE & CO. (US) | 1995-06-06 | — | — | US | claimed |